Triple-negative breast cancer (TNBC) is a heterogeneous clinicopathological entity defined as an estrogen receptor (ER)-, progesterone receptor (PR)- and HER2/neu-negative breast cancer (1). Here, PGR is linked to triple-negative breast carcinoma.